GT Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DRW SECURITIES, LLC | 11/14/2025 | 142.38 K | $83.51 K | 100.00% | 5.14% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 92.53 K | $54.59 K | 0.00% | 3.34% |
| CITADEL ADVISORS LLC | 11/14/2025 | 39.63 K | $23.56 K | 100.00% | 1.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 23.97 K | $14.25 K | 0.54% | 0.86% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 17.07 K | $10.01 K | 100.00% | 0.62% |
| MORGAN STANLEY | 11/14/2025 | 14.02 K | $8.22 K | 249.07% | 0.51% |
| VANGUARD GROUP INC | 11/07/2025 | 10.50 K | $6.25 K | 0.00% | 0.38% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 10.01 K | $5.87 K | 0.00% | 0.36% |
| BLACKROCK, INC. | 11/12/2025 | 9.74 K | $5.71 K | 0.00% | 0.35% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 5.07 K | $4.70 K | -55.72% | 0.18% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/13/2025 | 3.75 K | $2.20 K | 36.36% | 0.14% |
| UBS GROUP AG | 11/13/2025 | 2.63 K | $1.54 K | -54.80% | 0.09% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.70 K | $999 | 278.67% | 0.06% |
| CLEARSTEAD ADVISORS, LLC | 11/10/2025 | 865 | $508 | 0.00% | 0.03% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 300 | $230 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 24 | $14 | -17.24% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 16 | $9 | 0.00% | 0.00% |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 10/22/2025 | 10 | $6 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 5 | $3 | -16.67% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1 | $1 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 1 | $1 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| FRONT ROW ADVISORS LLC | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
| MOUNT YALE INVESTMENT ADVISORS, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GT Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 30 institutional investors and hedge funds held shares of GT Biopharma, Inc.. The most heavily invested institutionals were:
DRW Securities, LLC: 142,380
BANK OF MONTREAL /CAN/: 92,530
CITADEL ADVISORS LLC: 39,633
GEODE CAPITAL MANAGEMENT, LLC: 23,966
TWO SIGMA SECURITIES, LLC: 17,065
MORGAN STANLEY: 14,015
13.50% of GT Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 387.51 K shares in the last 24 months. This purchase volume represents approximately $247.46 K in transactions.